ID   RMA-S-A*2402
AC   CVCL_WK58
DR   Wikidata; Q98129117
RX   PubMed=17982631;
CC   Transfected with: HGNC; 4931; HLA-A (allele A*24:02).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2180 ! RMA-S
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 6
//
RX   PubMed=17982631; DOI=10.3892/or.18.6.1463;
RA   Komohara Y., Harada M., Ishihara Y., Suekane S., Noguchi M.,
RA   Yamada A., Matsuoka K., Itoh K.;
RT   "HLA-G as a target molecule in specific immunotherapy against renal
RT   cell carcinoma.";
RL   Oncol. Rep. 18:1463-1468(2007).
//